These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2423638)

  • 1. Anomalous behaviour of Newcastle disease virus haemagglutinin-neuraminidase protein in Western blotting analysis of monoclonal antibody binding sites.
    Samson AC
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1199-203. PubMed ID: 2423638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of haemagglutinin-neuraminidase antibody binding sites by Western blot analysis of antibody-resistant mutants and partial digest fragments of Newcastle disease virus.
    Samson AC; Nesbit M; Lyon AM; Meulemans G
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():473-80. PubMed ID: 3339333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Chambers P; Nesbit M; Yusoff K; Millar NS; Samson AC; Emmerson PT
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2115-22. PubMed ID: 2457068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.
    Russell PH
    Arch Virol; 1986; 90(1-2):135-44. PubMed ID: 3729723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of monoclonal antibody-resistant mutants of Newcastle disease virus.
    Samson AC; Russell PH; Hallam SE
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():357-61. PubMed ID: 3838186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amino acid substitutions on glycosylation of the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; Samson AC; Emmerson PT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1549-52. PubMed ID: 2471815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glycoproteins associated with proteolytic cleavage.
    Umino Y; Kohama T; Sato TA; Sugiura A; Klenk HD; Rott R
    J Gen Virol; 1990 May; 71 ( Pt 5)():1189-97. PubMed ID: 1693166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Iorio RM; Borgman JB; Glickman RL; Bratt MA
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1393-403. PubMed ID: 2425048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity.
    Long L; Portetelle D; Ghysdael J; Gonze M; Burny A; Meulemans G
    J Virol; 1986 Mar; 57(3):1198-202. PubMed ID: 2419585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus.
    Yusoff K; Nesbit M; McCartney H; Emmerson PT; Samson AC
    Virus Res; 1988 Nov; 11(4):319-33. PubMed ID: 2464879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptide.
    Garten W; Kohama T; Klenk HD
    J Gen Virol; 1980 Nov; 51(Pt 1):207-11. PubMed ID: 7463006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains.
    Millar NS; Chambers P; Emmerson PT
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():613-20. PubMed ID: 3351479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.
    Gotoh B; Sakaguchi T; Nishikawa K; Inocencio NM; Hamaguchi M; Toyoda T; Nagai Y
    Virology; 1988 Mar; 163(1):174-82. PubMed ID: 2450424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein.
    Hu S; Wang T; Liu Y; Meng C; Wang X; Wu Y; Liu X
    Vet Microbiol; 2010 Jan; 140(1-2):92-7. PubMed ID: 19729254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence analysis of the haemagglutinin-neuraminidase gene of Newcastle disease virus.
    Millar NS; Chambers P; Emmerson PT
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1917-27. PubMed ID: 3018130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 36K polypeptide synthesized in Newcastle disease virus-infected cells possesses properties predicted for the hypothesized 'V' protein.
    Samson AC; Levesley I; Russell PH
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1709-13. PubMed ID: 1856697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characterization of monoclonal antibodies to Newcastle disease virus.
    Russell PH; Griffiths PC; Goswami KK; Alexander DJ; Cannon MJ; Russell WC
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2069-72. PubMed ID: 6193248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies.
    Rydbeck R; Orvell C; Löve A; Norrby E
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1531-42. PubMed ID: 2426392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of monoclonal antibodies to Newcastle disease virus in passive immunization.
    Umino Y; Kohama T; Sato TA; Sugiura A
    J Gen Virol; 1990 May; 71 ( Pt 5)():1199-203. PubMed ID: 2345369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.